Compare XCBE & DAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XCBE | DAVI |
|---|---|---|
| Founded | 2025 | 2022 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.1M | 25.0M |
| IPO Year | 2025 | 2025 |
| Metric | XCBE | DAVI |
|---|---|---|
| Price | $10.06 | $1.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.7K | ★ 400.4K |
| Earning Date | N/A | 04-06-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.75 | $0.91 |
| 52 Week High | $10.06 | $6.05 |
| Indicator | XCBE | DAVI |
|---|---|---|
| Relative Strength Index (RSI) | 74.85 | 15.67 |
| Support Level | $9.88 | $0.91 |
| Resistance Level | N/A | $1.80 |
| Average True Range (ATR) | 0.00 | 0.25 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 100.00 | 15.54 |
X3 Acquisition Corp Ltd is a blank check company.
Davion Healthcare PLC is focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable. It designs, develops, and patents medical products and non-diagnostic devices and then licenses the manufacturing, marketing, sales, and distribution rights for its products to regional or world-wide commercial partners. The company has been operating as a single segment. Its products are BreastCheck, FootFlow, and Testic.